Combined Volumetric and Density Analyses of Contrast-Enhanced CT Imaging to Assess Drug Therapy Response in Gastroenteropancreatic Neuroendocrine Diffuse Liver Metastasis

Table 3

Tumor response evaluation with changes in total tumor volume and mean volumetric tumor density after treatment.

Tumor response by TRCIST version 1.1	Total tumor volumes	Mean volumetric tumor density	Patient no.	Total
Tumor progression	↑(287.3%, 31.8%, 81.3%)	↑(1.7%, 17.1%, 11.0%)	3	7
	↑ (296.0%, 131.2%, 112.5%)	↓ (31.7%, 4.7%, 24.2%)	3
	↓ (1.6%)	↓ (30.2%)	1
Tumor nonprogression	↓(88.7%, 74.6%)	↓(3.0%, 27.8%)	2	18
	↑ (57.9%, 43.5%)	↓ (14.5%, 13.1%)	2
	↓(28.7%, 27.5%)	↑(17.8%, 5.4%)	2
	↑	↑	12